-
1
-
-
84885337474
-
Familial risk-colorectal cancer: ESMO clinical practice guidelines
-
Balmaña J, Balaguer F, Cervantes A, et al: Familial risk-colorectal cancer: ESMO clinical practice guidelines. Ann Oncol 24:vi73-vi80, 2013 (suppl 6).
-
(2013)
Ann Oncol
, vol.24
, pp. vi73-vi80
-
-
Balmaña, J.1
Balaguer, F.2
Cervantes, A.3
-
3
-
-
10744233937
-
Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
-
Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 261-268
-
-
Umar, A.1
Boland, C.R.2
Terdiman, J.P.3
-
4
-
-
17944362664
-
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
-
Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352: 1851-1860, 2005.
-
(2005)
N Engl J Med
, vol.352
, pp. 1851-1860
-
-
Hampel, H.1
Frankel, W.L.2
Martin, E.3
-
5
-
-
20244386395
-
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
-
Piñol V, Castells A, Andreu M, et al: Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986-1994, 2005.
-
(2005)
JAMA
, vol.293
, pp. 1986-1994
-
-
Piñol, V.1
Castells, A.2
Andreu, M.3
-
6
-
-
0029585997
-
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome
-
Aarnio M, Mecklin JP, Aaltonen LA, et al: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433, 1995.
-
(1995)
Int J Cancer
, vol.64
, pp. 430-433
-
-
Aarnio, M.1
Mecklin, J.P.2
Aaltonen, L.A.3
-
7
-
-
70350090521
-
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
-
Stoffel E, Mukherjee B, Raymond VM, et al: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621-1627, 2009.
-
(2009)
Gastroenterology
, vol.137
, pp. 1621-1627
-
-
Stoffel, E.1
Mukherjee, B.2
Raymond, V.M.3
-
8
-
-
84860605783
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
-
Win AK, Young JP, Lindor NM, et al: Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol 30:958-964, 2012.
-
(2012)
J Clin Oncol
, vol.30
, pp. 958-964
-
-
Win, A.K.1
Young, J.P.2
Lindor, N.M.3
-
9
-
-
0034011564
-
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
-
Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000.
-
(2000)
Gastroenterology
, vol.118
, pp. 829-834
-
-
Järvinen, H.J.1
Aarnio, M.2
Mustonen, H.3
-
10
-
-
30944457531
-
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
-
Schmeler KM, Lynch HT, Chen LM, et al: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261-269, 2006.
-
(2006)
N Engl J Med
, vol.354
, pp. 261-269
-
-
Schmeler, K.M.1
Lynch, H.T.2
Chen, L.M.3
-
11
-
-
84875036048
-
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome
-
Win AK, Lindor NM, Winship I, et al: Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 105:274-279, 2013.
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 274-279
-
-
Win, A.K.1
Lindor, N.M.2
Winship, I.3
-
12
-
-
84870747205
-
Risks of less common cancers in proven mutation carriers with lynch syndrome
-
Engel C, Loeffler M, Steinke V, et al: Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:4409-4415, 2012.
-
(2012)
J Clin Oncol
, vol.30
, pp. 4409-4415
-
-
Engel, C.1
Loeffler, M.2
Steinke, V.3
-
13
-
-
14644396669
-
Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium
-
Plaschke J, Engel C, Krüger S, et al: Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22:4486-4494, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4486-4494
-
-
Plaschke, J.1
Engel, C.2
Krüger, S.3
-
14
-
-
33749029656
-
Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium
-
Goecke T, Schulmann K, Engel C, et al: Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium. J Clin Oncol 24:4285-4292, 2006.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4285-4292
-
-
Goecke, T.1
Schulmann, K.2
Engel, C.3
-
15
-
-
0035886698
-
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families
-
Vasen HF, Stormorken A, Menko FH, et al: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080, 2001.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4074-4080
-
-
Vasen, H.F.1
Stormorken, A.2
Menko, F.H.3
-
16
-
-
48549099663
-
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
-
Senter L, Clendenning M, Sotamaa K, et al: The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135: 419-428, 2008.
-
(2008)
Gastroenterology
, vol.135
, pp. 419-428
-
-
Senter, L.1
Clendenning, M.2
Sotamaa, K.3
-
17
-
-
84905562208
-
Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome
-
Batte BA, Bruegl AS, Daniels MS, et al: Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome. Gynecol Oncol 134:319-325, 2014.
-
(2014)
Gynecol Oncol
, vol.134
, pp. 319-325
-
-
Batte, B.A.1
Bruegl, A.S.2
Daniels, M.S.3
-
18
-
-
50049124155
-
Extraintestinal manifestations of familial adenomatous polyposis
-
Groen EJ, Roos A, Muntinghe FL, et al: Extraintestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 15:2439-2450, 2008.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2439-2450
-
-
Groen, E.J.1
Roos, A.2
Muntinghe, F.L.3
-
19
-
-
33846074011
-
Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature
-
Nieuwenhuis MH, Vasen HF: Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature. Crit Rev Oncol Hematol 61:153-161, 2007.
-
(2007)
Crit Rev Oncol Hematol
, vol.61
, pp. 153-161
-
-
Nieuwenhuis, M.H.1
Vasen, H.F.2
-
20
-
-
0037468517
-
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH
-
Sieber OM, Lipton L, Crabtree M, et al: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791-799, 2003.
-
(2003)
N Engl J Med
, vol.348
, pp. 791-799
-
-
Sieber, O.M.1
Lipton, L.2
Crabtree, M.3
-
21
-
-
33947280508
-
Identification of MYH mutation carriers in colorectal cancer: A multicenter, case-control, populationbased study
-
Balaguer F, Castellví-Bel S, Castells A, et al: Identification of MYH mutation carriers in colorectal cancer: A multicenter, case-control, populationbased study. Clin Gastroenterol Hepatol 5:379-387, 2007.
-
(2007)
Clin Gastroenterol Hepatol
, vol.5
, pp. 379-387
-
-
Balaguer, F.1
Castellví-Bel, S.2
Castells, A.3
-
22
-
-
84864506477
-
Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas
-
Grover S, Kastrinos F, Steyerberg EW, et al: Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 308:485-492, 2012.
-
(2012)
JAMA
, vol.308
, pp. 485-492
-
-
Grover, S.1
Kastrinos, F.2
Steyerberg, E.W.3
-
23
-
-
20244386256
-
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X
-
Lindor NM, Rabe K, Petersen GM, et al: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 293:1979-1985, 2005.
-
(2005)
JAMA
, vol.293
, pp. 1979-1985
-
-
Lindor, N.M.1
Rabe, K.2
Petersen, G.M.3
-
24
-
-
80052696774
-
Fourteen years of evolution of ESMO guidelines: From the minimum recommendations to the consensus conference-derived guidelines
-
Pavlidis N, Stahel R, Hansen H, et al: Fourteen years of evolution of ESMO guidelines: From the minimum recommendations to the consensus conference-derived guidelines. Ann Oncol 22:vi7- vi11, 2011 (suppl 6).
-
(2011)
Ann Oncol
, vol.22
, pp. vi7-vi11
-
-
Pavlidis, N.1
Stahel, R.2
Hansen, H.3
-
25
-
-
84867122727
-
ESMO consensus guidelines for management of patients with colon and rectal cancer: A personalized approach to clinical decision making
-
Schmoll HJ, Van Cutsem E, Stein A, et al: ESMO consensus guidelines for management of patients with colon and rectal cancer: A personalized approach to clinical decision making. Ann Oncol 23:2479-2516, 2012.
-
(2012)
Ann Oncol
, vol.23
, pp. 2479-2516
-
-
Schmoll, H.J.1
Van Cutsem, E.2
Stein, A.3
-
26
-
-
84905595139
-
Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer
-
Giardiello FM, Allen JI, Axilbund JE, et al: Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 109:1159-1179, 2014.
-
(2014)
Am J Gastroenterol
, vol.109
, pp. 1159-1179
-
-
Giardiello, F.M.1
Allen, J.I.2
Axilbund, J.E.3
-
27
-
-
83955161674
-
Longterm effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
-
Burn J, Gerdes AM, Macrae F, et al: Longterm effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet 378: 2081-2087, 2011.
-
(2011)
Lancet
, vol.378
, pp. 2081-2087
-
-
Burn, J.1
Gerdes, A.M.2
Macrae, F.3
-
28
-
-
84889084275
-
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations
-
Makar KW, Poole EM, Resler AJ, et al: COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 24:2059-2075, 2013.
-
(2013)
Cancer Causes Control
, vol.24
, pp. 2059-2075
-
-
Makar, K.W.1
Poole, E.M.2
Resler, A.J.3
-
29
-
-
33947492472
-
Cox-2 and cancer chemoprevention: Picking up the pieces
-
Bertagnolli MM: Cox-2 and cancer chemoprevention: Picking up the pieces. Recent Results Cancer Res 174:73-78, 2007.
-
(2007)
Recent Results Cancer Res
, vol.174
, pp. 73-78
-
-
Bertagnolli, M.M.1
-
30
-
-
59849129653
-
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
-
Palomaki GE, McClain MR, Melillo S, et al: EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42-65, 2009.
-
(2009)
Genet Med
, vol.11
, pp. 42-65
-
-
Palomaki, G.E.1
McClain, M.R.2
Melillo, S.3
-
31
-
-
84867499525
-
Identification of Lynch syndrome among patients with colorectal cancer
-
Moreira L, Balaguer F, Lindor N, et al: Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555-1565, 2012.
-
(2012)
JAMA
, vol.308
, pp. 1555-1565
-
-
Moreira, L.1
Balaguer, F.2
Lindor, N.3
-
32
-
-
59849108362
-
Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
-
Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35-41, 2009.
-
(2009)
Genet Med
, vol.11
, pp. 35-41
-
-
-
33
-
-
84863609627
-
Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National society of genetic counselors and the collaborative group of the americas on inherited colorectal cancer joint practice guideline
-
Weissman SM, Burt R, Church J, et al: Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns 21:484-493, 2012.
-
(2012)
J Genet Couns
, vol.21
, pp. 484-493
-
-
Weissman, S.M.1
Burt, R.2
Church, J.3
-
34
-
-
58149144567
-
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3= exons of TACSTD1
-
Ligtenberg MJ, Kuiper RP, Chan TL, et al: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3= exons of TACSTD1. Nat Genet 41:112-117, 2009.
-
(2009)
Nat Genet
, vol.41
, pp. 112-117
-
-
Ligtenberg, M.J.1
Kuiper, R.P.2
Chan, T.L.3
-
35
-
-
67650383819
-
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
-
Niessen RC, Hofstra RM, Westers H, et al: Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 48:737-744, 2009.
-
(2009)
Genes Chromosomes Cancer
, vol.48
, pp. 737-744
-
-
Niessen, R.C.1
Hofstra, R.M.2
Westers, H.3
-
36
-
-
78650692633
-
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study
-
Kempers MJ, Kuiper RP, Ockeloen CW, et al: Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study. Lancet Oncol 12:49-55, 2011.
-
(2011)
Lancet Oncol
, vol.12
, pp. 49-55
-
-
Kempers, M.J.1
Kuiper, R.P.2
Ockeloen, C.W.3
-
37
-
-
80052479865
-
Evaluation of guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort
-
Munck A, Gargouri L, Alberti C, et al: Evaluation of guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort. J Pediatr Gastroenterol Nutr 53:296-302, 2011.
-
(2011)
J Pediatr Gastroenterol Nutr
, vol.53
, pp. 296-302
-
-
Munck, A.1
Gargouri, L.2
Alberti, C.3
|